Questionnaire of the Section Perioperative Intensive Care of the European Society of Intensive Care Medicine (ESICM) on Standardized Drug Labelling

Completed

• Conditions: Drug Labelling

• Registration Number: NCT01232088
• Lead Sponsor: Charite University, Berlin, Germany

Brief Summary

Medication errors are common in intensive care (Valentin A et al., BMJ. 2009;338). Standardized color coded labels for user applied syringes enjoy strong support from many health professionals, thinking that this might increase patient safety. Whether this is true or not warrants further research.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-11
• Study First Submitted: 2010-11-01
• Study First Submitted QC: 2010-11-01
• Study First Posted: 2010-11-02
• Primary Completion: 2011-06
• Study Completion: 2011-09
• Status Verified: 2015-10
• Last Update Submitted: 2015-10-30
• Last Update Posted: 2015-11-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 482

Inclusion Criteria

Members of the European Society of Intensive Care Medicine (ESICM)

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary objective is to assess if standardized drug syringe labelling is used in European ICUs.	A period of 90 days.	Online survey for ICU physicians (members of the ESICM).

Secondary Outcome Measures

Name	Time	Method
The second objectives is to assess 1. if standards for drug syringe labelling are similar in European ICUs and 2. if users expect that standardized drug syringe labelling should be delivered by the pharmaceutical industry.	A period of 90 days	Online survey for ICU physicians (members of the ESICM).

Trial Locations

Locations (1)

Department of Anesthesiology and Intensive Care Medicine Campus Virchow Klinikum/Campus Charité Mitte; 🇩🇪 Berlin, Germany